DNV, the independent global assurance and risk management provider, is partnering with Korean AI-driven blood and cancer ...

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's ...

Manifold Health AI was created after identifying a fundamental limitation in the at-home diagnostics market: while self-administered blood collection technology is now exceptional, devices alone do ...

The Global Alzheimer's Platform Foundation(R) (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, to the Bio-Hermes-002 study.

Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) ...

Tal Parnes, Chairman of the Board of Inspira Technologies, stated: “The contemplated acquisition of this liquid biopsy platform represents a significant value inflection point for Inspira, adding a ...

Health Secretary Robert F. Kennedy Jr. is backing research into the lymphatic system and psychedelic drugs to reverse aging.

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at ...

Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...

India’s IT services industry has long prioritised data security due to global client requirements. DPDP changes the nature of ...